文献速递腹部MR

钆塞酸增强MRI多参数评估预测肝细胞癌微血管侵犯

Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
PubMed 文献 · Abdom Radiol (NY) · 2024-02-15

回顾性单中心研究纳入345例患者356个肝细胞癌,用钆塞酸增强MRI九项征象预测微血管侵犯,多因素分析筛选出肿瘤直径、肿瘤廓清和肝胆期瘤周低信号,构建预测公式在训练集AUC 0.88、验证集1 0.81、验证集2 0.67,三组AUC无显著差异。

要点

  • 肿瘤直径、肿瘤廓清、肝胆期瘤周低信号与微血管侵犯独立相关。
  • 预测公式在训练集AUC 0.88,验证集1为0.81,验证集2为0.67。
  • 三组AUC两两比较均无显著差异(P=0.15、0.09、0.29)。

核心结论

  • 钆塞酸增强MRI多参数评估预测微血管侵犯表现相当精确且可重复性良好。

研究设计与样本

  • 回顾性单中心研究,345例患者356个肝细胞癌,肝切除患者数据为训练集,肝切除患者为验证集1,肝移植患者为验证集2,参考标准为手术病理。

关键影像表现/征象

  • 肿瘤直径与微血管侵犯显著相关(P=0.021)。
  • 肿瘤廓清与微血管侵犯显著相关(P<0.01)。
  • 肝胆期瘤周低信号与微血管侵犯显著相关(P<0.01)。

诊断标准与关键数值

  • 预测公式诊断微血管侵犯的AUC:训练集0.88(95%CI 0.82,0.93)。
  • 验证集1的AUC为0.81(95%CI 0.73,0.87)。
  • 验证集2的AUC为0.67(95%CI 0.51,0.80)。
  • 三组AUC比较:训练集 vs 验证集1 P=0.15,训练集 vs 验证集2 P=0.09,验证集1 vs 验证集2 P=0.29,均无显著差异。

临床应用与阅片要点

  • 阅片时可关注肿瘤直径、肿瘤廓清和肝胆期瘤周低信号三项征象用于预测微血管侵犯。
  • 预测公式在肝切除与肝移植患者中AUC分别为0.81和0.67,三组间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To elucidate how precisely microvascular invasion (MVI) in hepatocellular carcinoma (HCC) can be predicted using multiparametric assessment of gadoxetic acid-enhanced MRI.

METHODS: In this retrospective single-center study, patients who underwent liver resection or transplantation of HCC were evaluated. Data obtained in patients who underwent liver resection were used as the training set. Nine kinds of MR findings for predicting MVI were compared between HCCs with and without MVI by univariate analysis, followed by multiple logistic regression analysis. Using significant findings, a predictive formula for diagnosing MVI was obtained. The diagnostic performance of the formula was investigated in patients who underwent liver resection (validation set 1) and in patients who underwent liver transplantation (validation set 2) using a receiver operating characteristic curve analysis. The area under the curves (AUCs) of these three groups were compared.

RESULTS: A total of 345 patients with 356 HCCs were selected for analysis. Tumor diameter (D) (P = 0.021), tumor washout (TW) (P < 0.01), and peritumoral hypointensity in the hepatobiliary phase (PHH) (P < 0.01) were significantly associated with MVI after multivariate analysis. The AUCs for predicting MVI of the predictive formula were as follows: training set, 0.88 (95% confidence interval (CI) 0.82,0.93); validation set 1, 0.81 (95% CI 0.73,0.87); validation set 2, 0.67 (95% CI 0.51,0.80). The AUCs were not significantly different among three groups (training set vs validation set 1; P = 0.15, training set vs validation set 2; P = 0.09, validation set 1 vs validation set 2; P = 0.29, respectively).

CONCLUSION: Our multiparametric assessment of gadoxetic acid-enhanced MRI performed quite precisely and with good reproducibility for predicting MVI.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Fujita N, Ushijima Y, Ishimatsu K, et al. Multiparametric assessment of microvascular invasion in hepatocellular carcinoma using gadoxetic acid-enhanced MRI. Abdom Radiol (NY). 2024. PMID: 38360959. doi:10.1007/s00261-023-04179-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。